Correction
for
Pasquet et al., Circulation 100 (2) 141-148.
Circulation. 1999;100:1584
(Circulation. 1999;100:1584.)
© 1999 American Heart Association, Inc.
Correction
 |
Introduction
|
|---|
In the article by Pasquet et al that appeared in a previous
issue
of the journal (
Circulation. 1999;100:141148), the
legends
of Figures 4

and 5

contained errors. The corrected
information
appears here.

View larger version (14K):
[in this window]
[in a new window]
|
Figure 4. Kaplan-Meier estimates of cardiac mortality in
patients with (RVS) and without (MED)
revascularization and with (Is) and without (NIs)
ischemic myocardium by thallium
scintigraphy (Tl) (A) or dobutamine
echocardiography (Db) (B).
|
|

View larger version (14K):
[in this window]
[in a new window]
|
Figure 5. Kaplan-Meier estimates of cardiac mortality in
patients with (RVS) and without (MED)
revascularization and with (V) and without (NV)
residual viable myocardium, as determined by thallium
scintigraphy (Tl) (A) or dobutamine
echocardiography (Db) (B).
|
|
This article has been cited by other articles:

|
 |

|
 |
 
A. Tawakol and H. Gewirtz
Does CABG Improve Left Ventricular Ejection Fraction in Patients with Ischemic Cardiomyopathy, and Does It Matter?
J. Nucl. Med.,
January 1, 2001;
42(1):
87 - 0.
[Full Text]
[PDF]
|
 |
|